CO.DON AG INH. O.N.
Research CO.DON AG INH. O.N. (CNW) on Bullrun: market cap EUR 360.77K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCNW
- ExchangeF
- CountryGermany
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 360.77K
- Financial periodFY2024
- RevenueEUR 20.00K
- Revenue growth-99.7%
- Net income-EUR 340.00K
- Free cash flowEUR 430.00K
- Gross margin100.0%
Valuation Snapshot
latest market cap is EUR 360.77K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | EUR 20.00K | -EUR 340.00K | EUR 430.00K | 100.0% | n/a | EUR 13.45M | n/a | EUR 3.57M |
| FY2023 | EUR 6.06M | -EUR 250.00K | -EUR 1.35M | 95.7% | n/a | EUR 13.02M | n/a | EUR 3.91M |
| FY2022 | EUR 6.24M | -EUR 16.98M | -EUR 8.90M | 68.8% | -0.74 | EUR 2.05M | EUR 2.98M | EUR 4.88M |
| FY2021 | EUR 9.80M | -EUR 9.32M | -EUR 8.45M | 94.4% | -0.41 | EUR 6.54M | EUR 6.25M | EUR 17.57M |
| FY2020 | EUR 6.23M | -EUR 13.87M | -EUR 9.98M | 72.9% | -1.29 | EUR 9.13M | EUR 5.98M | EUR 20.61M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | EUR 360.77K | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About CO.DON AG INH. O.N.
co.don AG does not have significant operations. Previously, the company was engaged in the development, production, and marketing of biopharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is CO.DON AG INH. O.N.'s market cap?
CO.DON AG INH. O.N.'s market capitalization is EUR 360.77K.
What does CO.DON AG INH. O.N. do?
co.don AG does not have significant operations. Previously, the company was engaged in the development, production, and marketing of biopharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.